Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Taiwan University Hospital |
---|---|
Information provided by: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT00172380 |
To assess the overall response rate to docetaxel plus CDDP as neoadjuvant chemotherapy prior to surgery, followed by adjuvant docetaxel plus CDDP in chemonaive patients NSCLC Stage IIIa and IIIb.
Condition | Intervention | Phase |
---|---|---|
NSCLC |
Drug: Docetaxel Plus CDDP |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Phase II Study Evaluating Docetaxel and CDDP as Neoadjuvant Chemotherapy Prior to Surgery, Followed by Adjuvant Docetaxel Plus CDDP in Chemonaive Patients With NSCLC Stage III |
Ages Eligible for Study: | 20 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-Histologically or cytologically confirmed NSCLC, respectable NSCLC stage IIIa T1-2 N2 or or unresectable stage IIIb 2.KPS>70%
3.Hb>10g/dl,ANC>2.0x109/L,Plt.>100x109/L4.T-bil.<1xULN,creatinine<1xULN,creatinine clearance >60 ml/min,GPT/GOT<2.5xULN,ALP<5xULN
Exclusion Criteria:
Contact: Yung-chie Lee, M.D.,Ph.D. | 886-2 ext 5070 | wuj@ha.mc.ntu.edu.tw |
Taiwan | |
Department of Oncology, Nationa Taiwan University Hospital | Recruiting |
Taipei, Taiwan, 100 | |
Contact: yung-chie Lee, M.D.,Ph.D. 886-2-23123456 ext 5070 wuj@ha.mc.ntu.edu.tw | |
Principal Investigator: Yung-Chie Lee, M.D.,Ph.D. |
Principal Investigator: | Yung-chie Lee, M.D,Ph.D. | Department of Surgery, National Taiwan University hospital |
Study ID Numbers: | 930911 |
Study First Received: | September 12, 2005 |
Last Updated: | November 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00172380 History of Changes |
Health Authority: | Taiwan: Department of Health |
Docetaxel Adjuvants, Immunologic Non-small Cell Lung Cancer |
Docetaxel Antineoplastic Agents Therapeutic Uses Pharmacologic Actions |